Botulinum toxin for the treatment of oro-facial-lingual-masticatory tardive dyskinesia
2000; Wiley; Volume: 15; Issue: 2 Linguagem: Inglês
10.1002/1531-8257(200003)15
ISSN1531-8257
AutoresAbraham Rapaport, Menachem Sadeh, Daniel E. Stein, Joseph Levine, Pinhas Sirota, Tania Mosheva, Shaul Stir, A Elitzur, Ilia Reznik, Diklah Geva, J. M. Rabey,
Tópico(s)Parkinson's Disease Mechanisms and Treatments
ResumoMovement DisordersVolume 15, Issue 2 p. 352-355 Clinical/Scientific Notes Botulinum toxin for the treatment of oro-facial-lingual-masticatory tardive dyskinesia Abraham Rapaport MD, Corresponding Author Abraham Rapaport MD Department of Neurology, Wolfson Medical Center, Holon, Israel, Sackler School of Medicine, Tel Aviv University, Tel Aviv, IsraelThe Department of Neurology, Wolfson Medical Center, PO Box 5, Holon 58100, IsraelSearch for more papers by this authorMenachem Sadeh, Menachem Sadeh Department of Neurology, Wolfson Medical Center, Holon, Israel, Sackler School of Medicine, Tel Aviv University, Tel Aviv, IsraelSearch for more papers by this authorDaniel Stein, Daniel Stein Sheba Medical Center, Tel Hashomer, Sackler School of Medicine, Tel Aviv University, Tel Aviv, IsraelSearch for more papers by this authorJoseph Levine, Joseph Levine Beer Sheva Mental Health Center, Beer Sheva, IsraelSearch for more papers by this authorPinhas Sirota, Pinhas Sirota Abarbanel Mental Health Center, Bat Yam, Israel, Sackler School of Medicine, Tel Aviv University, Tel Aviv, IsraelSearch for more papers by this authorTania Mosheva, Tania Mosheva Abarbanel Mental Health Center, Bat Yam, Israel, Sackler School of Medicine, Tel Aviv University, Tel Aviv, IsraelSearch for more papers by this authorShaul Stir, Shaul Stir Abarbanel Mental Health Center, Bat Yam, Israel, Sackler School of Medicine, Tel Aviv University, Tel Aviv, IsraelSearch for more papers by this authorAvner Elitzur, Avner Elitzur Abarbanel Mental Health Center, Bat Yam, Israel, Sackler School of Medicine, Tel Aviv University, Tel Aviv, IsraelSearch for more papers by this authorIlia Reznik, Ilia Reznik Abarbanel Mental Health Center, Bat Yam, Israel, Sackler School of Medicine, Tel Aviv University, Tel Aviv, IsraelSearch for more papers by this authorDiklah Geva, Diklah Geva Department of Biostatistics and Epidemiology, Wolfson Medical Center, Holon, IsraelSearch for more papers by this authorJ. Martin Rabey, J. Martin Rabey Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel, Department of Neurology, Assaf Harofe Hospital, Tzrifin, IsraelSearch for more papers by this author Abraham Rapaport MD, Corresponding Author Abraham Rapaport MD Department of Neurology, Wolfson Medical Center, Holon, Israel, Sackler School of Medicine, Tel Aviv University, Tel Aviv, IsraelThe Department of Neurology, Wolfson Medical Center, PO Box 5, Holon 58100, IsraelSearch for more papers by this authorMenachem Sadeh, Menachem Sadeh Department of Neurology, Wolfson Medical Center, Holon, Israel, Sackler School of Medicine, Tel Aviv University, Tel Aviv, IsraelSearch for more papers by this authorDaniel Stein, Daniel Stein Sheba Medical Center, Tel Hashomer, Sackler School of Medicine, Tel Aviv University, Tel Aviv, IsraelSearch for more papers by this authorJoseph Levine, Joseph Levine Beer Sheva Mental Health Center, Beer Sheva, IsraelSearch for more papers by this authorPinhas Sirota, Pinhas Sirota Abarbanel Mental Health Center, Bat Yam, Israel, Sackler School of Medicine, Tel Aviv University, Tel Aviv, IsraelSearch for more papers by this authorTania Mosheva, Tania Mosheva Abarbanel Mental Health Center, Bat Yam, Israel, Sackler School of Medicine, Tel Aviv University, Tel Aviv, IsraelSearch for more papers by this authorShaul Stir, Shaul Stir Abarbanel Mental Health Center, Bat Yam, Israel, Sackler School of Medicine, Tel Aviv University, Tel Aviv, IsraelSearch for more papers by this authorAvner Elitzur, Avner Elitzur Abarbanel Mental Health Center, Bat Yam, Israel, Sackler School of Medicine, Tel Aviv University, Tel Aviv, IsraelSearch for more papers by this authorIlia Reznik, Ilia Reznik Abarbanel Mental Health Center, Bat Yam, Israel, Sackler School of Medicine, Tel Aviv University, Tel Aviv, IsraelSearch for more papers by this authorDiklah Geva, Diklah Geva Department of Biostatistics and Epidemiology, Wolfson Medical Center, Holon, IsraelSearch for more papers by this authorJ. Martin Rabey, J. Martin Rabey Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel, Department of Neurology, Assaf Harofe Hospital, Tzrifin, IsraelSearch for more papers by this author First published: 31 January 2001 https://doi.org/10.1002/1531-8257(200003)15:2 3.0.CO;2-XCitations: 21AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL References 1Jankovic J, Brin MF. Therapeutic uses of botulinum toxin. N Engl J Med 1991; 324: 1186– 1194. 2Mauriello JA Jr, Leone T, Dhilon S, Pakeman B, Mostafavi R, Yepez MC. Treatment choices of 119 patients with hemifacial spasm over 11 years. Clin Neurol Neurosurg 1996; 98: 213– 216. 3Dutton JJ. Botulinum-A toxin in the treatment of craniocervical muscle spasms: short and long-term local and systemic effects. Surv Ophthalmol 1996; 41: 51– 65. 4Chatterjee A, Forrest GM, Giladi N, Trosch R. Botulinum toxin in the treatment of tardive dystonia. J Clin Psychopharmacol 1997; 17: 497– 498. 5Yasufuku-Takano J, Sakurai M, Kanazawa I, Nagoka M. Successful treatment of intractable tardive dyskinesia with botulinum toxin. J Neurol Neurosurg Psychiatry 1995; 58: 511– 512. 6Jankovic J. Tardive syndromes and other drug-induced movement disorders. Clin Neuropharmacol 1995; 18: 197– 214. 7Egan MF, Apud J, Wyatt RJ. Treatment of tardive dyskinesia. Schizophr Bull 1997; 23: 583– 609. 8 Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington, DC: American Psychiatric Press, 1994. 9Abnormal Involuntary Movement Scale (AIMS) and Tardive Dyskinesia Rating Scale (TDRS). Psychopharmacol Bull 1988; 24: 781– 783. 10Borodic GE. Hemifacial spasm, evaluation and management with emphasis on botulinum toxin therapy. In: J Jankovic, M Hallett, eds. Therapy with Botulinum Toxin. New York, NY: Marcel Dekker, 1994: 331– 353. Citing Literature Volume15, Issue2March 2000Pages 352-355 ReferencesRelatedInformation
Referência(s)